Bactrim Dosing and Duration for MRSA Skin Abscess
For an adult with a skin abscess requiring MRSA coverage, prescribe trimethoprim-sulfamethoxazole 1-2 double-strength tablets (160/800 mg) twice daily for 5-10 days, with duration based on clinical response.
Dosing Recommendations
Standard Adult Dosing
- 1-2 double-strength tablets (160/800 mg or 320/1600 mg) twice daily 1
- The FDA label specifies this dosing range for skin and soft tissue infections 2
Evidence for Higher vs. Standard Dosing
The higher dose (320/1600 mg twice daily) has been extensively studied:
- A large randomized trial of 1,247 patients demonstrated that 320/1600 mg twice daily for 7 days resulted in 80.5% clinical cure versus 73.6% with placebo (P=0.005) 3
- However, an observational study found no difference in clinical resolution between high-dose (320/1600 mg) and standard-dose (160/800 mg) therapy for MRSA skin infections 4
Practical recommendation: Start with 1-2 double-strength tablets twice daily. The higher dose (2 tablets = 320/1600 mg) is supported by the strongest randomized trial evidence and is reasonable for confirmed or suspected MRSA.
Duration of Therapy
Outpatient Abscess Treatment
- 5-10 days is the guideline-recommended duration 5
- Most high-quality trials used 7-10 days 6, 3
- Extend beyond 5 days if infection has not improved 1
Duration Matters for MRSA
A pediatric trial found that 10 days was superior to 3 days for MRSA abscesses:
- Treatment failure: 10.1% higher with 3-day course (P=0.03)
- Recurrence at 1 month: 10.3% higher with 3-day course (P=0.046) 7
Practical recommendation: Use 7-10 days for confirmed or suspected MRSA. Reserve 5-day courses only for mild infections with rapid clinical improvement.
When Antibiotics Are Indicated
Abscess Management Algorithm
Incision and drainage alone may be sufficient for simple abscesses, but antibiotics provide clear benefit 6, 3. The guidelines recommend antibiotics for abscesses with 5:
- Severe or extensive disease (multiple sites)
- Rapid progression with associated cellulitis
- Systemic signs (fever, tachycardia)
- Comorbidities or immunosuppression
- Extremes of age
- Difficult-to-drain locations (face, hand, genitalia)
- Lack of response to drainage alone
Evidence Supporting Antibiotic Use
Two major trials demonstrated benefit:
- Clindamycin or TMP-SMX improved cure rates from 68.9% (placebo) to 81-83% (antibiotics) in abscesses ≤5 cm 6
- TMP-SMX reduced subsequent drainage procedures (3.4% vs 8.6%), new infections (3.1% vs 10.3%), and household transmission (1.7% vs 4.1%) 3
- Benefits occurred regardless of lesion size or presence of guideline criteria 8
Clinical Pearls and Pitfalls
Common Pitfalls to Avoid
- Don't assume drainage alone is adequate: Even for small abscesses, antibiotics reduce failure and recurrence rates
- Don't use 3-day courses for MRSA: This increases treatment failure and recurrence 7
- Don't combine with rifampin: Rifampin as adjunctive therapy for skin infections is not recommended 5
When to Consider Alternative Agents
TMP-SMX has limitations:
- No streptococcal coverage: If purulent cellulitis with concern for streptococci, add amoxicillin or use clindamycin alone 5
- Gastrointestinal side effects: Occur more frequently than placebo but are generally mild 3
- Variable resistance: Canadian data shows good TMP-SMX susceptibility, but clindamycin resistance exceeds 40% 9